AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 JUL 14 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) and Henry Schein (HSIC) announced that Henry Schein has been selected as the exclusive U.S. distributor of MedImmune's FluMist (Influenza Virus Vaccine Live, Intranasal) for the upcoming flu season.
MedImmune, which has exclusive rights to manufacture and market FluMist, will oversee all sales and marketing activities with special emphasis on pediatricians and pharmacies. In addition to selling FluMist, Henry Schein will respond to customer product inquiries, process returns, and promote the product through marketing initiatives to primary care physicians.
MedImmune also has substantially reduced the price of FluMist to approximately one-half of what the vaccine was available for last season. Henry Schein will sell ...